Compare ON & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ON | BNTX |
|---|---|---|
| Founded | 1992 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5B | 24.7B |
| IPO Year | 2000 | 2019 |
| Metric | ON | BNTX |
|---|---|---|
| Price | $74.10 | $98.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 13 |
| Target Price | $65.29 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 8.3M | 949.2K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $5,878,300,000.00 | N/A |
| Revenue This Year | $7.93 | N/A |
| Revenue Next Year | $8.90 | $3.37 |
| P/E Ratio | $151.78 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.56 | $79.81 |
| 52 Week High | $134.92 | $124.00 |
| Indicator | ON | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.50 | N/A |
| Support Level | $70.92 | N/A |
| Resistance Level | $74.98 | N/A |
| Average True Range (ATR) | 2.81 | 0.00 |
| MACD | 0.64 | 0.00 |
| Stochastic Oscillator | 75.30 | 0.00 |
Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and one of the largest suppliers of image sensors to the automotive market. Its chips sell into vehicle drivetrains, automotive safety systems, energy infrastructure, industrial automation, and data centers. Onsemi manufactures most of its products in-house, vertically integrated from design to production. Its sales are split between direct and distribution, and it holds a global manufacturing and customer footprint.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.